Signum Biosciences' Debt - II Round

Signum Biosciences raised a round of funding on April 20, 2007. Investors include New Jersey Economic Development Authority.

Signum Biosciences is a biotechnology company dedicated to developing small-molecule therapeutics derived from the Signal Transduction Modulation (STM) platform to modulate signal transduction imbalan…

Articles about Signum Biosciences' Debt - II Round: